Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Immunology

Internal Medicine

Pediatrics

Public Health, Environmental And Occupational Health

Show all topics

DOI

10.1016/s0140-6736(21)00943-0

Other Formats

PDF